Biocon gains on entering into business transfer agreement with BBIL

24 Jan 2018 Evaluate

Biocon is currently trading at Rs. 649.60, up by 7.80 points or 1.22% from its previous closing of Rs. 641.80 on the BSE.

The scrip opened at Rs. 640.00 and has touched a high and low of Rs. 657.75 and Rs. 628.05 respectively. So far 260963 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 657.75 on 24-Jan-2018 and a 52 week low of Rs. 294.71 on 25-May-2017.

Last one week high and low of the scrip stood at Rs. 657.75 and Rs. 536.75 respectively. The current market cap of the company is Rs. 38508.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 20.39% and 18.94% respectively.

Biocon has entered into a Business Transfer Agreement (BTA) with its step down wholly owned subsidiary, Biocon Biologics India (BBIL) on January 22, 2018, for the transfer of its Biosimilars business to BBIL.

The proposed transfer of Biosimilars business would enable consolidation of the development, commercialization and manufacturing of all Biosimilars businesses under a single structure.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×